BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 33169934)

  • 1. Tacrines as Therapeutic Agents for Alzheimer's Disease. V. Recent Developments.
    Bautista-Aguilera ÓM; Ismaili L; Iriepa I; Diez-Iriepa D; Chabchoub F; Marco-Contelles J; Pérez M
    Chem Rec; 2021 Jan; 21(1):162-174. PubMed ID: 33169934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Tacrines as Anti-Alzheimer's Disease Agents. The (Benzo)Chromeno- PyranoTacrines.
    Oset-Gasque MJ; Marco-Contelles J
    Curr Top Med Chem; 2017; 17(31):3349-3360. PubMed ID: 29332585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Developments on Multi-Target-Directed Tacrines for Alzheimer's Disease. I. The Pyranotacrines.
    Romero A; Marco-Contelles J
    Curr Top Med Chem; 2017; 17(31):3328-3335. PubMed ID: 29332586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tacrines as Therapeutic Agents for Alzheimer's Disease. IV. The Tacripyrines and Related Annulated Tacrines.
    Bartolini M; Marco-Contelles J
    Chem Rec; 2019 May; 19(5):927-937. PubMed ID: 30489012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel tacrine-coumarin hybrids linked to 1,2,3-triazole as anti-Alzheimer's compounds: In vitro and in vivo biological evaluation and docking study.
    Najafi Z; Mahdavi M; Saeedi M; Karimpour-Razkenari E; Edraki N; Sharifzadeh M; Khanavi M; Akbarzadeh T
    Bioorg Chem; 2019 Mar; 83():303-316. PubMed ID: 30396115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological assessment of KojoTacrines as new agents for Alzheimer's disease therapy.
    Dgachi Y; Martin H; Malek R; Jun D; Janockova J; Sepsova V; Soukup O; Iriepa I; Moraleda I; Maalej E; Carreiras MC; Refouvelet B; Chabchoub F; Marco-Contelles J; Ismaili L
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):163-170. PubMed ID: 30482062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel tacrine analogs as potential cholinesterase inhibitors in Alzheimer's disease.
    El-Malah A; Gedawy EM; Kassab AE; Salam RM
    Arch Pharm (Weinheim); 2014 Feb; 347(2):96-103. PubMed ID: 24343873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Merged Tacrine-Based, Multitarget-Directed Acetylcholinesterase Inhibitors 2015-Present: Synthesis and Biological Activity.
    Eckroat TJ; Manross DL; Cowan SC
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conjugates of tacrine and 1,2,4-thiadiazole derivatives as new potential multifunctional agents for Alzheimer's disease treatment: Synthesis, quantum-chemical characterization, molecular docking, and biological evaluation.
    Makhaeva GF; Kovaleva NV; Boltneva NP; Lushchekina SV; Rudakova EV; Stupina TS; Terentiev AA; Serkov IV; Proshin AN; Radchenko EV; Palyulin VA; Bachurin SO; Richardson RJ
    Bioorg Chem; 2020 Jan; 94():103387. PubMed ID: 31735356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ROS-responsive and multifunctional anti-Alzheimer prodrugs: Tacrine-ibuprofen hybrids via a phenyl boronate linker.
    Liu Z; Zhang B; Xia S; Fang L; Gou S
    Eur J Med Chem; 2021 Feb; 212():112997. PubMed ID: 33189440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, and molecular-modeling study of aminothienopyridine analogues of tacrine for Alzheimer's disease.
    Badran MM; Abdel Hakeem M; Abuel-Maaty SM; El-Malah A; Abdel Salam RM
    Arch Pharm (Weinheim); 2010 Oct; 343(10):590-601. PubMed ID: 20925094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New (benz)imidazolopyridino tacrines as nonhepatotoxic, cholinesterase inhibitors for Alzheimer disease.
    Boulebd H; Ismaili L; Martin H; Bonet A; Chioua M; Marco Contelles J; Belfaitah A
    Future Med Chem; 2017 May; 9(8):723-729. PubMed ID: 28485637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and neuroprotective evaluation of novel tacrine-benzothiazole hybrids as multi-targeted compounds against Alzheimer's disease.
    Keri RS; Quintanova C; Marques SM; Esteves AR; Cardoso SM; Santos MA
    Bioorg Med Chem; 2013 Aug; 21(15):4559-69. PubMed ID: 23768661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, acetylcholinesterase inhibition and neuroprotective activity of new tacrine analogues.
    León R; Marco-Contelles J; García AG; Villarroya M
    Bioorg Med Chem; 2005 Feb; 13(4):1167-75. PubMed ID: 15670925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isoxazolotacrines as non-toxic and selective butyrylcholinesterase inhibitors for Alzheimer's disease.
    Cherif O; Allouche F; Chabchoub F; Chioua M; Soriano E; Yañez M; Cacabelos R; Romero A; López MG; Marco-Contelles J
    Future Med Chem; 2014; 6(17):1883-91. PubMed ID: 25495982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, pharmacology and molecular docking on multifunctional tacrine-ferulic acid hybrids as cholinesterase inhibitors against Alzheimer's disease.
    Zhu J; Yang H; Chen Y; Lin H; Li Q; Mo J; Bian Y; Pei Y; Sun H
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):496-506. PubMed ID: 29405075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chlorinated tacrine analogs: Design, synthesis and biological evaluation of their anti-cholinesterase activity as potential treatment for Alzheimer's disease.
    Ragab HM; Teleb M; Haidar HR; Gouda N
    Bioorg Chem; 2019 May; 86():557-568. PubMed ID: 30782574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tacrine-propargylamine derivatives with improved acetylcholinesterase inhibitory activity and lower hepatotoxicity as a potential lead compound for the treatment of Alzheimer's disease.
    Mao F; Li J; Wei H; Huang L; Li X
    J Enzyme Inhib Med Chem; 2015 Dec; 30(6):995-1001. PubMed ID: 25792506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, physicochemical and biological evaluation of tacrine derivative labeled with technetium-99m and gallium-68 as a prospective diagnostic tool for early diagnosis of Alzheimer's disease.
    Gniazdowska E; Koźmiński P; Halik P; Bajda M; Czarnecka K; Mikiciuk-Olasik E; Masłowska K; Rogulski Z; Cheda Ł; Kilian K; Szymański P
    Bioorg Chem; 2019 Oct; 91():103136. PubMed ID: 31374521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of tacrine-huperzine A hybrids as acetylcholinesterase inhibitors of potential interest for the treatment of Alzheimer's disease.
    Badia A; Baños JE; Camps P; Contreras J; Görbig DM; Muñoz-Torrero D; Simón M; Vivas NM
    Bioorg Med Chem; 1998 Apr; 6(4):427-40. PubMed ID: 9597187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.